TRUSTED. GEBT is the only FDA-approved (PMA) breath test intended to be used for measurements of the rate of solid phase gastric emptying and aid in the diagnosis of gastroparesis in human subjects. GEBT is validated against the method of gastric scintigraphy.
SAFE. GEBT is a non-radioactive, non-invasive alternative to scintigraphy. GEBT can be administered in a doctor’s office or in clinic setting because it does not require healthcare professionals administering the test to undergo special training in radiation safety or radioactive materials. GEBT can be administered repeatedly and as often as every 24 hours.
CONSISTENT. GEBT is standardized. Test results are quantitative and comparable across all clinical testing sites and across patient evaluations. Standardization and non-use of radioactive material makes GEBT particularly suitable for multi-site, national and global clinical studies.
TESTED. In addition to the stringent FDA PMA approval process, GEBT has also been used in over 40 major clinical trials and administered to over 4,500 patients. GEBT has an excellent safety profile.
TRUSTED. GEBT is the only FDA-approved (PMA) breath test intended to be used for measurements of the rate of solid phase gastric emptying and aid in the diagnosis of gastroparesis in human subjects. GEBT is validated against the method of gastric scintigraphy.
SAFE. GEBT is a non-radioactive, non-invasive alternative to scintigraphy. GEBT can be administered in a doctor’s office or in clinic setting because it does not require healthcare professionals administering the test to undergo special training in radiation safety or radioactive materials. GEBT can be administered repeatedly and as often as every 24 hours.
CONSISTENT. GEBT is standardized. Test results are quantitative and comparable across all clinical testing sites and across patient evaluations. Standardization and non-use of radioactive material makes GEBT particularly suitable for multi-site, national and global clinical studies.
TESTED. In addition to the stringent FDA PMA approval process, GEBT has also been used in over 40 major clinical trials and administered to over 4,500 patients. GEBT has an excellent safety profile.
